Agilent and BPL Are Buying the Missing Pieces of the Stack
Device and diagnostics vendors are using M&A to fill workflow, software, and distribution gaps and build harder-to-displace platforms.
What is this trend?
Medical device and diagnostics companies are buying adjacent software, workflow, and distribution assets to own more of the full stack and make their platforms harder to replace.
- Acquisitions are replacing partnerships as the fastest way to fill product and workflow gaps.
- Regulatory-ready software and embedded clinical workflows are becoming core M&A targets.
- Owning distribution, manufacturing, or interoperability can make hardware portfolios stickier.
- The benchmark is stack completeness: vendors need end-to-end capability, not just a strong point product.
What’s the latest?
How it developed
- Orchestration, compliance, and utilization are reshaping medtech value, while interoperable stacks gain ground
- Neurotherapy Competition Moves to Interoperable Workflow Stacks
- Subscription Care Stacks, Drone-Enabled Last-Mile Monitoring, and Interoperability as the New AID Moat
- Interoperability Is Becoming the AID Competitive Moat
- Subscription CGM pull-through, tighter AI compliance, and imaging supply control reshape care delivery
- Imaging Platforms Are Extending Into Supply, Manufacturing, and AI Workflow Control
- Reimbursement proof, AI compliance software, robotics distribution control, and stack consolidation
- Agilent and BPL Are Buying the Missing Pieces of the Stack
Go deeper
Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.
If you operate in this industry
If you sell into this industry
AI Bot Wars Prompt Rethink of Prior Authorization in RevCycle
YouTube analysis on AI-driven prior auth, interoperable claims data, and subscription RCM strategy as the moat.
Lifers with Christina Farr · YouTube

Perceptive Discovery and Nucleus RadioPharma Announce Strategic Partnership to Accelerate Radiopharmaceutical Development from Target to Clinic
Promotion news on a partnership linking preclinical imaging to GMP radiopharma manufacturing and AI workflow control.
PR Newswire - General Business · News
Read →Fuse Oncology Shows S!GNAL Integration at ASTRO 2026
Analysis featuring James Bauler on S!GNAL integration at ASTRO 2026 and interoperability as an AI revenue moat.
SaasRise · News
Read →